MATERNAL AND FETAL OUTCOMES IN HYPERTENSIVE DISORDERS OF PREGNANCY: AN OBSERVATIONAL STUDY AT A TERTIARY CARE CENTRE
Main Article Content
Keywords
Hypertensive disorders, Preeclampsia, Eclampsia, Maternal outcomes, Fetal outcomes, Gestational hypertension.
Abstract
Background: Hypertensive disorders of pregnancy (HDP) ranks among the foremost contributors to maternal and perinatal morbidity and mortality across the globe. These disorders encompass a continuum that ranges from gestational hypertension to more severe conditions such as preeclampsia, eclampsia, and HELLP syndrome. The early identification and judicious management of these conditions are paramount to enhancing outcomes, particularly in resource-limited settings. This study aimed to evaluate the maternal and fetal outcomes associated with hypertensive disorders of pregnancy within a tertiary care framework.
Methods: A prospective observational study was conducted at the Department of Obstetrics and Gynaecology, ESIC Medical College and Hospital, Joka, Kolkata, from November 2023 to November 2024. A total of 100 women diagnosed with HDP beyond 20 weeks of gestation were enrolled. Detailed clinical assessment, investigations, and follow-up evaluations were meticulously performed. Maternal outcomes such as mode of delivery and complications, and fetal outcomes including birth weight, gestational age, NICU admission, and perinatal mortality were recorded and analyzed.
Results: The incidence of HDP among all deliveries during the study period was 6%. Gestational hypertension was the most common subtype (78%), followed by preeclampsia (10%). Primigravida women constituted 68% of the cases. Caesarean section was performed in 84% of patients, while 30% had preterm deliveries. The most common maternal complication was postpartum eclampsia (12%), and the most frequent fetal outcomes included low birth weight (28%), intrauterine growth restriction (15%), NICU admission (16%), and neonatal death (2%). A statistically significant association was found between the type of HDP and adverse maternal and fetal outcomes.
Conclusion: HDP continues to present significant threats to maternal and neonatal health. Timely identification, appropriate antenatal care, and swift referral to specialized centers are paramount in mitigating complications. Strengthening perinatal care pathways and instituting standardized management protocols can profoundly enhance outcomes.
References
2. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102:181–192.
3. Shey Wiysonge CU, Ngu Blackett K, Mbuagbaw JN. Risk factors and complications of hypertension in Yaoundé, Cameroon. Cardiovasc J S Afr. 2004;15:215–219.
4. Schroeder BM. ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. Am Fam Physician. 2002;66:330–331.
5. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 222: Gestational hypertension and preeclampsia. Obstet Gynecol. 2020;135(6):e237–e260.
6. Singhal SR, Deepika A, Nanda S. Maternal and perinatal outcome in severe pre-eclampsia and eclampsia. J South Asian Fed Obstet Gynecol. 2009;1:25–28.
7. Un Nisa S, Shaikh AA, Kumar R. Maternal and fetal outcomes of pregnancy-related hypertensive disorders in a tertiary care hospital in Sukkur, Pakistan. Cureus. 2019;11(8):e5507.
8. Leeners B, Rath W, Kuse S, Irawan C, Imthurn B, Neumaier-Wagner P. BMI: new aspects of a classical risk factor for hypertensive disorders in pregnancy. Clin Sci (Lond). 2006;111:81–86.
9. Peterson EV, Hivert MF, Fleisch AF, Calafat AM, Sagiv BSK, Perng W, et al. Early pregnancy plasma per- and polyfluoroalkyl substance concentrations and hypertensive disorders of pregnancy in the Project Viva cohort. Environ Int. 2022;165:107335.
10. Anh NTH, Thang NM, Huong TT. Maternal and perinatal outcomes of hypertensive disorders in pregnancy: insights from National Hospital of Obstetrics and Gynecology in Vietnam. PLoS One. 2024;19(1):e0297302.
11. Prakash J, Pandey LK, Singh AK, Kar B. Hypertension in pregnancy: hospital based study. J Assoc Physicians India. 2006;54:273–278.
12. Sultana A, Haider F, Arif S. Maternal and perinatal outcomes in eclampsia: a study in a tertiary care centre. J Med Sci Clin Res. 2020;8(7):12–16.
13. Gupta R, Avasthi K, Bhatia N. Maternal and perinatal outcomes in pregnancy induced hypertension in a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2021;10(2):656–660.
14. Kumari S, Devi PK, Rajput R. Fetomaternal outcome in hypertensive disorders of pregnancy. Int J Med Sci Educ. 2017;4(2):92–97.
15. Singh S, Madaan M, Chawla S. Maternal and neonatal outcomes in hypertensive disorders of pregnancy. J Obstet Gynecol India. 2015;65(4):238–244.
16. Begum J, Samal S, Ghose S. Perinatal outcomes in women with hypertensive disorders of pregnancy: a multicentre study. Int J Reprod Contracept Obstet Gynecol. 2020;9(11):4460–4466.
17. Jain L, Choudhary A, Rathore AM. Maternal and fetal outcomes in HELLP syndrome: a study in Indian scenario. Int J Med Sci Public Health. 2016;5(10):2043–2047.
18. Dutta DC, Konar H. Hypertensive disorders in pregnancy. In: Dutta’s Textbook of Obstetrics. 9th ed. New Delhi: Jaypee Brothers; 2018. p. 301–318.
19. Naik PR, Jajoo S, Ingle R. Study of fetomaternal outcome in hypertensive disorders of pregnancy. Indian J Appl Res. 2018;8(9):19–21.
20. Rani N, Vani S, Malik S. Primigravida and risk of preeclampsia: a clinical correlation. J South Asian Fed Obstet Gynecol. 2017;9(1):8–11.
21. Patel PK, Maheshwari R, Pawar MM. Early identification and effective management of hypertensive disorders in pregnancy. Int J Clin Obstet Gynaecol. 2021;5(6):307–311.
22. Bhosale M, Nalawade D, Kshirsagar A. Maternal and fetal outcomes in hypertensive pregnancies: a review. Int J Med Health Res. 2023;9(1):15–20.